Hackensack Meridian Health sells off majority of its long-term care facilities to Complete Care

Hackensack Meridian Health , New Jersey’s largest health network, recently announced it has signed a definitive agreement with Complete Care to acquire a majority of its long-term care facilities. 

Hackensack said the long-term care industry has experienced major changes over the last few years as a result of the COVID-19 pandemic, and this decision was made in line with what it says are industry trends and best practices. Complete Care has extensive experience in long-term care operations and management. Upon closing, Hackensack Meridian Health and Complete Care will maintain a care collaboration relationship to ensure the delivery of quality care for hospital patients and residents that is clinically integrated through the care continuum.

“Hackensack Meridian Health is focused on transforming the continuum of care for the patients, team members and communities we serve,”  “After careful consideration over the past several months, we have decided to partner with Complete Care, a leading provider of short-term post-acute rehabilitation, and long-term and specialty care, for them to acquire the majority of our long-term care facilities,” said Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health.

The facilities being acquired include Hackensack Meridian Health nursing and subacute facilities located in Brick, Hackensack, Holmdel, North Bergen, Ocean Grove, Plainfield, Shrewsbury and Wall, as well as two assisted living facilities located in Edison and Holmdel. 

“We are honored to enter into this agreement with Hackensack Meridian Health. As leaders of our industries, this is a perfect alignment. Complete Care is a family owned and operated New Jersey based company that shares a commitment to advancing the health and well-being of the senior communities served by the network,” explained Sam Stein, CEO, Complete Care. “Our success in the long-term care industry is made possible by our dedicated, experienced management team, which is comprised of Licensed Nursing Home Administrators and our more than 4,000 caring and committed staff members statewide.”

Related Long-term Care Content:

Nearly all nursing homes are hurting, but should the for-profits get more free money?

Nursing homes report highest COVID case totals to-date, plead to Congress for help

Testing AL and nursing homes for COVID-19 would cost $672M

Hospital payments have dropped $250B

Poll: Older Americans unsure how to pay for long-term care

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.